openPR Logo
Press release

mRNA Synthesis Raw Materials Market Survey Detailed Analysis and Forecast 2023-2031

12-08-2023 12:14 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Insightace analytic

mRNA Synthesis Raw Materials Market Survey Detailed Analysis

InsightAce Analytic Pvt. Ltd. announced the publication of a market research report titled "Global mRNA Synthesis Raw Materials Market by Product Type (Capping Enzymes, DNA Templates, Nucleotides, And Polymerase), Application (Therapeutics Production, Vaccine Production, And Drug Discovery), End-User (Biotechnology Companies, Pharmaceutical Companies, Research and Academic Institutes, And Others))- Market Outlook and Industry Analysis 2031" .

The mRNA Synthesis Raw Materials Market Size is valued at USD 3070.2 Million in 2022 and is predicted to reach USD 14912.9 Million by the year 2031 at a 20.0% CAGR during the forecast period for 2023-2031.

Get Sample copy of the Global mRNA Synthesis Raw Materials Market Report at https://www.insightaceanalytic.com/request-sample/1497

The prominent market players include Thermo Fisher Scientific, Inc, Jena Bioscience, Sartorius AG, Cytiva, Moderna, Inc, H3 Biomedicine Inc, Kernal Biologics, Ziphius Therapeutics, Merck KGaA, miRagen Therapeutics, Inc., Skyhawk Therapeutics, Inc, Tiba Biotechnology, CureVac, Translate Bio, Sigma Aldrich, BOC Sciences, Roche CustomBiotech and TriLink Bio Technologies.

A DNA nucleotide sequence is used as a template to produce messenger RNA in the nucleus. The term transcription is used to characterize this process. Beginning, elongating, editing, and concluding are four distinct procedures. Bacteriophages, DNA templates, RNA polymerase, and nucleotide triphosphates (NTPs) are essential components. Medical technology advancements propel the market. The market for RNA synthesis raw materials is also driven by the introduction of new products by prominent pharmaceutical companies, which improves service quality.

The increasing prevalence of cancer and chronic diseases has increased the demand for gene therapies. Healthcare professionals and the general public are becoming more aware of the importance of treating chronic diseases at an early stage. The mRNA vaccine has demonstrated remarkable potential and utility in unpredictable situations, such as the spread of COVID, due to its numerous benefits, such as its rapid production time, low production cost, and prolonged immune response. Due to the advantages of mRNA vaccines, the global vaccine industry, which is also the market for the essential materials used in mRNA synthesis, has experienced an increase in demand. Due to the increasing demand for gene therapies, chronic and infectious diseases, and the number of clinical trials for cancer treatments and contagious diseases, the need for mRNA synthesis raw materials is expected to increase significantly.

Due to their strategy of offering higher-quality and more efficient products, the leading market participants have a growing demand for high-quality raw materials for practical mRNA synthesis. Market expansion is anticipated to be fueled by increased public and healthcare professional awareness of the importance of early detection and treatment of chronic diseases. This is necessary to develop safe and efficacious pharmaceuticals, vaccines, and drugs. In addition, the market is driven by the alliances, mergers, and partnerships formed by key competitors to enhance the supply of raw materials. New pharmaceutical company innovations, enhanced quality and efficacy of services, increased facility customization, and improved medical technologies all contribute to the expansion of the market.
However, a lack of adaptable, durable, and cost-effective manufacturing processes hinders the growth of mRNA synthesis raw materials. The expensive cost of raw materials is the primary growth inhibitor. In addition, the expansion of the market is constrained by the need for greater public awareness.

The market for mRNA synthesis raw materials in North America is anticipated to expand significantly in the coming years. Due to the prevalence of numerous mRNA vaccine production facilities, the United States is expected to continue to lead the industry. The United States has well-established production facilities for mRNA vaccines and therapies developed by leading corporations such as Pfizer and Moderna. This will aid this region's continued dominance throughout the projected period. In addition, Asia-Pacific had a significant share of the mRNA synthesis raw materials market due to increased expenditure on R&D, an increase in the prevalence of infectious diseases, and the rapid adoption of cutting-edge technologies.

Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1497

Key Market Developments
• In Nov 2022, Sartorius and The BASE announced a partnership to facilitate mutual development processes and protocols tailored for varied nucleic acid-based products. The collaboration will leverage BASE's advanced manufacturing and analytics capabilities, including novel next-generation sequencing approaches to co-develop protocols and nucleic acid-based product production methods.
• In Oct 2022, Thermo Fisher Scientific introduced a tailored Dynabeads solution that, according to the company, helps the production and purification of mRNA for vaccine research and manufacture. Messenger RNA (mRNA) synthesis and purification can be aided by the use of Dynabeads Streptavidin for in vitro transcription and Dynabeads for carboxylic acid for RNA purification solutions in the development and manufacturing of vaccines.
• In July 2022, Kernel Biologics, Inc. completed a $25 million Series A fundraising. Kernal's mRNA 2.0 platform will be expanded, and an IND for Kernal's immuno-oncology candidate KR-335 will be filed. Kernal Bio is building on the traditional mRNA technology and remarkable achievements of Moderna and Pfizer/BioNTech. Market Segmentation.
• In Aug 2021, Sanofi signed a definitive agreement to purchase the outstanding shares of Translate Bio, a messenger RNA (mRNA) treatments firm. The acquisition is part of Sanofi's ambition to accelerate the use of mRNA technology in developing medicines and vaccines. Sanofi is expected to use the transaction to advance its currently licenced vaccination programmes and explore new therapeutic applications.
Market Segmentation:

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1497

Global mRNA Synthesis Raw Materials Market, by Product Type, 2023-2031 (Value US$ Mn)

• Capping Enzymes
• DNA template
• Nucleotides
• Polymerase

Global mRNA Synthesis Raw Materials Market, by Application, 2023-2031 (Value US$ Mn)

• Therapeutics Production
• Vaccine Production
• Drug Discovery

Global mRNA Synthesis Raw Materials Market, by the End-user, 2023-2031 (Value US$ Mn)

• Biotechnology Companies
• Pharmaceutical Companies
• Research and Academic Institutes
• Others

Global mRNA Synthesis Raw Materials Market, by Region, 2023-2031 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America mRNA Synthesis Raw Materials Market, by Country, 2023-2031 (Value US$ Mn)
• U.S.
• Canada
Europe mRNA Synthesis Raw Materials Market, by Country, 2023-2031 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific mRNA Synthesis Raw Materials Market, by Country, 2023-2031 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America mRNA Synthesis Raw Materials Market, by Country, 2023-2031 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa mRNA Synthesis Raw Materials Market, by Country, 2023-2031 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

For More Information @ https://www.insightaceanalytic.com/customisation/1497

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the Global mRNA Synthesis Raw Materials Market.
 To receive an industry overview and future trends of the mRNA Synthesis Raw Materials Market.
 To analyze the Global mRNA Synthesis Raw Materials Market drivers and challenges.
 To get information on the Global mRNA Synthesis Raw Materials Market size- (Value US$ Mn) forecast to 2031.
 Noteworthy investments, mergers & acquisitions in the Global mRNA Synthesis Raw Materials Market industry

Other Related Reports Published by InsightAce Analytic:
Global mRNA Synthesis and Manufacturing Services Market
Global mRNA Treatment Market
Global Cell & Gene Therapy Raw Material Testing Market
Global mRNA Extraction and Purification Market
Global Lipid Nanoparticles (LNPs) CDMO Market
Global Advanced Therapy Medicinal Products CDMO Market

For More Information: https://www.insightaceanalytic.com/report/mrna-synthesis-raw-materials-market/1497

Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release mRNA Synthesis Raw Materials Market Survey Detailed Analysis and Forecast 2023-2031 here

News-ID: 3320934 • Views:

More Releases from Insightace analytic

Digital Pathology Market Report- Expansive Coverage on the Profit Sources
Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031" The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031 "Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by
Digital Diabetes Management Market Report on the Untapped Growth Opportunities in the Industry
Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 2031
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031" The Global Data Center Liquid Cooling Market is estimated

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and